TA
TFB Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Buy |
899
+253
| +39% | +$133K | 0.12% | 189 |
|
|
2025
Q1 | $410K | Buy |
646
+7
| +1% | +$4.44K | 0.12% | 198 |
|
|
2024
Q4 | $455K | Sell |
639
-77
| -11% | -$54.8K | 0.13% | 177 |
|
|
2024
Q3 | $753K | Buy |
716
+30
| +4% | +$31.5K | 0.22% | 105 |
|
|
2024
Q2 | $721K | Sell |
686
-5
| -0.7% | -$5.26K | 0.23% | 96 |
|
|
2024
Q1 | $624K | Buy |
691
+318
| +85% | +$287K | 0.23% | 99 |
|
|
2023
Q4 | $328K | Sell |
373
-240
| -39% | -$211K | 0.17% | 117 |
|
|
2023
Q3 | $504K | Buy |
613
+63
| +11% | +$51.8K | 0.61% | 47 |
|
|
2023
Q2 | $395K | Buy |
550
+130
| +31% | +$93.4K | 0.17% | 139 |
|
|
2023
Q1 | $345K | Buy |
420
+57
| +16% | +$46.8K | 0.26% | 74 |
|
|
2022
Q4 | $262K | Buy |
+363
| New | +$262K | 0.22% | 98 |
|